MacroGenics, Inc.
MGNX
$1.31
-$0.06-4.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -166.10% | -127.39% | 201.16% | -6.66% | -13.28% |
| Total Depreciation and Amortization | -13.74% | 11.88% | 1.33% | -1.63% | -3.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 116.64% | -551.35% | -3.37% | 30.67% | 42.08% |
| Change in Net Operating Assets | -565.12% | 163.93% | -235.98% | 2,129.53% | -101.17% |
| Cash from Operations | -22.09% | -163.84% | 235.24% | 2.54% | -62.80% |
| Capital Expenditure | 14.68% | -4.73% | 42.80% | 29.06% | -135.32% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 0.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -75.22% | 16.55% | -25.38% | 84.33% | -33.44% |
| Cash from Investing | -76.12% | 16.48% | -24.96% | 91.32% | -36.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 2,550.00% | -99.05% | -76.09% | 863.14% |
| Repurchase of Common Stock | -6,950.00% | 94.59% | -1,133.33% | 99.75% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -281.94% | 327.94% | -110.88% | 152.02% | -9.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,259.25% | -96.64% | 2,575.23% | 117.36% | -286.30% |